墨西哥婴儿血管瘤诊断和治疗指南。

IF 0.6 Q4 PEDIATRICS
Mirna E Toledo-Bahena, Karen A Camargo-Sánchez, Helena Vidaurri-De la Cruz, Adriana M Valencia-Herrera, M Mar Sáez-de Ocáriz, Mario R Duarte-Abdala, Julieta Osuna-Osuna, Jessica Aranda-Mendoza, Gloria M Rosales-Solís, Gibert Maza-Ramos, M Luz Orozco-Covarrubias, Pablo Lezama-Del Valle, Julio R Erdmenger-Orellana, Rocío Enríquez-García, Pilar Dies-Suárez, Alejandro Celis-Jiménez, Carlos A Mena-Cedillos
{"title":"墨西哥婴儿血管瘤诊断和治疗指南。","authors":"Mirna E Toledo-Bahena, Karen A Camargo-Sánchez, Helena Vidaurri-De la Cruz, Adriana M Valencia-Herrera, M Mar Sáez-de Ocáriz, Mario R Duarte-Abdala, Julieta Osuna-Osuna, Jessica Aranda-Mendoza, Gloria M Rosales-Solís, Gibert Maza-Ramos, M Luz Orozco-Covarrubias, Pablo Lezama-Del Valle, Julio R Erdmenger-Orellana, Rocío Enríquez-García, Pilar Dies-Suárez, Alejandro Celis-Jiménez, Carlos A Mena-Cedillos","doi":"10.24875/BMHIM.24000069","DOIUrl":null,"url":null,"abstract":"<p><p>Infantile hemangioma is a benign vascular tumor, the most common in childhood, whose natural evolution is the disappearance of the lesion in the pediatric age and which has effective and safe treatments that limit its growth and favor its disappearance at younger ages. Infantile hemangioma continues to be a reason for attention to complications, due to erroneous diagnoses, lack of knowledge of the condition, late referral or fear of the effects of the medications used for its treatment. Furthermore, its presence is normalized without taking into account that it can cause uncertainty, anxiety, feelings of guilt and, as a consequence, a significant impact on the quality of life, mainly in the parents or caregivers of the child. The need for a clinical practice guideline in our country arises from the high presentation of late-remitted complications in infantile hemangioma even with the availability of adequate treatments, the continuous evolution of medicine and the appearance of new evidence. Throughout the guide you will find recommendations regarding the diagnosis, treatment and follow-up of patients with infantile hemangioma, taking into account the paraclinical tests that can be performed, topical or systemic management options, as well as adjuvant therapies. For the first time, objective tools for patient follow-up are included in a guide for the management of infantile hemangioma, as well as to help the first contact doctor in timely referral.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 Supl 2","pages":"1-28"},"PeriodicalIF":0.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Guía mexicana para el diagnóstico y el tratamiento del hemangioma infantil.\",\"authors\":\"Mirna E Toledo-Bahena, Karen A Camargo-Sánchez, Helena Vidaurri-De la Cruz, Adriana M Valencia-Herrera, M Mar Sáez-de Ocáriz, Mario R Duarte-Abdala, Julieta Osuna-Osuna, Jessica Aranda-Mendoza, Gloria M Rosales-Solís, Gibert Maza-Ramos, M Luz Orozco-Covarrubias, Pablo Lezama-Del Valle, Julio R Erdmenger-Orellana, Rocío Enríquez-García, Pilar Dies-Suárez, Alejandro Celis-Jiménez, Carlos A Mena-Cedillos\",\"doi\":\"10.24875/BMHIM.24000069\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Infantile hemangioma is a benign vascular tumor, the most common in childhood, whose natural evolution is the disappearance of the lesion in the pediatric age and which has effective and safe treatments that limit its growth and favor its disappearance at younger ages. Infantile hemangioma continues to be a reason for attention to complications, due to erroneous diagnoses, lack of knowledge of the condition, late referral or fear of the effects of the medications used for its treatment. Furthermore, its presence is normalized without taking into account that it can cause uncertainty, anxiety, feelings of guilt and, as a consequence, a significant impact on the quality of life, mainly in the parents or caregivers of the child. The need for a clinical practice guideline in our country arises from the high presentation of late-remitted complications in infantile hemangioma even with the availability of adequate treatments, the continuous evolution of medicine and the appearance of new evidence. Throughout the guide you will find recommendations regarding the diagnosis, treatment and follow-up of patients with infantile hemangioma, taking into account the paraclinical tests that can be performed, topical or systemic management options, as well as adjuvant therapies. For the first time, objective tools for patient follow-up are included in a guide for the management of infantile hemangioma, as well as to help the first contact doctor in timely referral.</p>\",\"PeriodicalId\":9103,\"journal\":{\"name\":\"Boletín médico del Hospital Infantil de México\",\"volume\":\"81 Supl 2\",\"pages\":\"1-28\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Boletín médico del Hospital Infantil de México\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24875/BMHIM.24000069\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Boletín médico del Hospital Infantil de México","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/BMHIM.24000069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

摘要

婴幼儿血管瘤是一种良性血管肿瘤,在儿童时期最为常见,其自然演变过程是在儿童时期病变消失,有效而安全的治疗方法可限制其生长,并有利于其在更小的年龄段消失。由于诊断错误、对病情缺乏了解、转诊过晚或害怕治疗药物的影响,婴幼儿血管瘤仍然是引起并发症的一个原因。此外,这种疾病的存在被认为是正常的,但却没有考虑到它可能会导致不确定性、焦虑和负罪感,并因此对生活质量产生重大影响,主要是对患儿的父母或看护者而言。我国之所以需要制定临床实践指南,是因为即使有适当的治疗方法,婴儿血管瘤晚期并发症的发生率仍然很高,而且医学在不断发展,新证据不断出现。在整本指南中,您将看到有关婴儿血管瘤患者诊断、治疗和随访的建议,其中考虑到了可以进行的临床旁检查、局部或全身治疗方案以及辅助疗法。该书首次将患者随访的客观工具纳入婴儿血管瘤治疗指南,并帮助首诊医生及时转诊。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Guía mexicana para el diagnóstico y el tratamiento del hemangioma infantil.

Infantile hemangioma is a benign vascular tumor, the most common in childhood, whose natural evolution is the disappearance of the lesion in the pediatric age and which has effective and safe treatments that limit its growth and favor its disappearance at younger ages. Infantile hemangioma continues to be a reason for attention to complications, due to erroneous diagnoses, lack of knowledge of the condition, late referral or fear of the effects of the medications used for its treatment. Furthermore, its presence is normalized without taking into account that it can cause uncertainty, anxiety, feelings of guilt and, as a consequence, a significant impact on the quality of life, mainly in the parents or caregivers of the child. The need for a clinical practice guideline in our country arises from the high presentation of late-remitted complications in infantile hemangioma even with the availability of adequate treatments, the continuous evolution of medicine and the appearance of new evidence. Throughout the guide you will find recommendations regarding the diagnosis, treatment and follow-up of patients with infantile hemangioma, taking into account the paraclinical tests that can be performed, topical or systemic management options, as well as adjuvant therapies. For the first time, objective tools for patient follow-up are included in a guide for the management of infantile hemangioma, as well as to help the first contact doctor in timely referral.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
73
审稿时长
20 weeks
期刊介绍: The Boletín Médico del Hospital Infantil de México is a bimonthly publication edited by the Hospital Infantil de México Federico Gómez. It receives unpublished manuscripts, in English or Spanish, relating to paediatrics in the following areas: biomedicine, clinical, public health, clinical epidemology, health education and clinical ethics. Articles can be original research articles, in-depth or systematic reviews, clinical cases, clinical-pathological cases, articles about public health, letters to the editor or editorials (by invitation).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信